100% Original Products
Fast Delivery within 24-72 Hours
Cash On Delivery Available
24/7 Order Support via whatsapp
Maczith (Azithromycin) effectively treats bacterial infections caused by susceptible organisms, including:
Respiratory Tract Infections: Pneumonia, bronchitis, sinusitis, pharyngitis/tonsillitis, otitis media
Skin & Soft Tissue Infections
Sexually Transmitted Infections: Non-gonococcal urethritis and cervicitis (Chlamydia trachomatis)
Targeted Delivery: High phagocyte concentration enables active transport to infection sites, achieving tissue levels >50x plasma concentrations.
Unique Pharmacokinetics:
Acid-stable formulation for optimal oral absorption (best on empty stomach)
Extended half-life (68 hours) supports once-daily dosing
Biliary excretion (primarily unchanged drug)
Microbial Action: Binds to 50S ribosomal subunit, inhibiting protein synthesis in susceptible strains.
Effective Against:
| Gram-Positive | Gram-Negative | Other Pathogens |
|---|---|---|
| Staphylococcus aureus | Haemophilus influenzae | Chlamydia pneumoniae |
| Streptococcus pneumoniae | Moraxella catarrhalis | Mycoplasma pneumoniae |
| Streptococcus pyogenes | Neisseria gonorrhoeae | Legionella pneumophila |
Oral Administration:
| Patient Group | Dosage Schedule | ||
|---|---|---|---|
| Adults | 500 mg daily à 3 days OR 500 mg Day 1 â 250 mg Days 2-5 | ||
| Chlamydia treatment | 1g single dose OR 500 mg Day 1 â 250 mg Days 2-3 | ||
| Children | 10 mg/kg once daily à 3 days (âĨ6 months) | ||
| Weight-based dosing | 15-25kg: 200 mg | 26-35kg: 300 mg | 36-45kg: 400 mg |
| Typhoid fever | 500 mg daily à 7-10 days |
IV Infusion (Adults Only):
Community-acquired pneumonia: 500 mg IV daily à âĨ2 days â switch to oral 500 mg to complete 7-10 days
Pelvic inflammatory disease: 500 mg IV daily à 1-2 days â oral 250 mg to complete 7 days (add anaerobic coverage if suspected)
Suspension Preparation:
Shake bottle â add cooled boiled water to marked line â shake until fully dissolved
Timing: Take 1 hour before or 2 hours after meals/antacids
| Interacting Drug | Clinical Recommendation |
|---|---|
| Antacids | Separate dosing by 1-2 hours |
| Cyclosporine | Monitor levels; adjust dose |
| Digoxin | Monitor for toxicity |
| Ergot Derivatives | Contraindicated (ergotism risk) |
| Warfarin | Monitor prothrombin time |
| Theophylline | No significant interaction observed |
Contraindications:
Hypersensitivity to macrolides
Hepatic impairment
Concurrent ergot derivatives
Common Side Effects (Typically mild/moderate):
Gastrointestinal (nausea, diarrhea, abdominal pain), rash, reversible transaminase elevation
Serious Reactions (Rare):
Angioedema, anaphylaxis, cholestatic jaundice, hearing loss (high-dose/long-term)
Pregnancy (Category B): Use only if alternatives inadequate
Lactation: Caution advised (excretion unknown)
Renal Impairment: No adjustment if CrCl >40 mL/min; caution if severe impairment
Hepatic Impairment: Avoid use (primary excretion route)
Symptoms: Hearing loss, severe GI distress
Treatment: Gastric lavage + supportive care
Macrolide Antibiotic
Store below 30°C in original packaging
Protect from light/moisture
Keep out of childrenâs reach
Medical Notice: Always use under supervision of a registered physician. Dosage may vary based on infection severity and patient response.
Â
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.
Comment